CCL2 expression is increased in AR-silenced C4-2 cells, and when AR is suppressed by ADT, prostate cancer-cell-derived CCL2, which mediates a local inflammatory response, plays a major role in tumor progression [76]. The gene discussed is CCL2; the disease is neoplasm.